Pharvaris N.V. (NASDAQ: PHVS)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 32.62 (0.00 / 0.00%) | 33.88 (+1.26 / +3.86%) | 33.88 (+0.00 / +0.00%) |
| 30-Jul 09:02 | 30-Jul 16:00 | 30-Jul 16:10 |
Sector: Healthcare || Industry: Biotechnology
| Previous Close | 32.62 | Year Low | 19.12 |
| Open | 32.62 | Year High | 36.60 |
| Day Low | 32.62 | Price Avg 50 | 32.53 |
| Day High | 34.48 | Price Avg 200 | 27.85 |
| Volume | 501.31 K | Market Cap | 2.37 B |
News
| Symbol | Catalyst News |
|---|---|
| PHVS | After a 96% 1-Year Run, This Director Sold 37,600 PHVS Shares for $1.3 Million. Is the Rally Over? Fool - Investing News | 2026-07-24 07:01:01 Here's Why Pharvaris N.V. (PHVS) is a Great Momentum Stock to Buy Zacks Investment Research | 2026-07-15 13:01:11 Wall Street Analysts Believe Pharvaris (PHVS) Could Rally 36.16%: Here's is How to Trade Zacks Investment Research | 2026-07-14 10:56:19 Pharvaris ($PHVS) Deucrictibant NDA Accepted by FDA for Review in HAE Catalyst picR | 2026-07-06 08:05:49 Pharvaris N.V. (PHVS) Presents at Bank of America Global Healthcare Conference 2026 Transcript Seeking Alpha | 2026-05-13 15:10:45 |
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| PHVS | 3.86 | 0.86 | -2.02 | 9.26 | 25.25 | 71.20 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/12/2026 | AMC | PHVS | Pharvaris | Q1 2026 | EPS | -0.77 | -0.69 | 10.39 | -0.89 | 22.50 | |
| 05/12/2026 | AMC | PHVS | Pharvaris | Q1 2026 | REV | ||||||
| 04/02/2026 | BMO | PHVS | Pharvaris | Q4 2025 | EPS | -0.69 | -0.84 | -21.74 | -0.68 | -23.50 | |
| 04/02/2026 | BMO | PHVS | Pharvaris | Q4 2025 | REV | 0.00 | 0.00 | ||||
| 11/12/2025 | BMO | PHVS | Pharvaris | Q3 2025 | EPS | -0.78 | -0.70 | 10.26 | -0.85 | 17.60 | |
| 11/12/2025 | BMO | PHVS | Pharvaris | Q3 2025 | REV | ||||||
| 08/12/2025 | AMC | PHVS | Pharvaris | Q2 2025 | EPS | -0.87 | -0.94 | -8.05 | -0.59 | -59.30 | |
| 08/12/2025 | AMC | PHVS | Pharvaris | Q2 2025 | REV | 0.00 | 0.00 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 06/25/2026 | PHVS | Morgan Stanley | Overweight | Overweight | Maintain |
| 05/13/2026 | PHVS | Citizens | Market Outperform | Market Outperform | Maintain |
| 04/07/2026 | PHVS | Wedbush | Outperform | Outperform | Maintain |
| 04/06/2026 | PHVS | RBC Capital | Outperform | Outperform | Maintain |
| 03/03/2026 | PHVS | HC Wainwright & Co. | Buy | Buy | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|
Sign-Up to see the full list of CATALYSTS in the Calendars
